08/24/2026
📊 New research presented at found that 42% of people stop taking GLP-1s within a year — and even more by year two.
Here's the piece that often gets missed: losing weight can actually work against you — many patients find their BMI has dropped just enough that insurance no longer covers the medication. Can you imagine? Has that happened to you?
That's where working with us can make a difference. At Grunberger Diabetes and Endocrinology, we don't just start you on a medication — we build a plan around your body, your goals, and what happens after you reach them.
At GDE we work alongside the medication to help you maintain your muscle mass, keep the weight off and help you find alternatives if your insurance wants to stop covering your medication. Whether that's Wegovy, another GLP-1, or a different treatment altogether depends on your health needs and insurance coverage.
For some patients, that means a structured plan to taper off with strategies to maintain results. For others, based on their metabolic health and goals, staying on treatment longer-term is the right path. Every body is different — and the plan should be too.
The goal isn't just weight loss. It's weight management - a sustainable strategy that avoids restarting again and again without direction.
Many People Who Stop Opt to Restart GLP-1 MedicationsA significant...